Fortitude Investment Partners · June 2024
Personalised medicine represents a significant evolution in healthcare. This approach customises medical treatment based on individual genetic, lifestyle and environmental factors, offering a departure from the traditional one-size-fits-all model. By tailoring care to the unique characteristics of each patient, personalised medicine aims to improve treatment outcomes, reduce side effects, and enhance overall health.
Our whitepaper explores the key drivers of this rapidly growing market, which is projected to expand from approximately $540 billion in 2022 to an estimated $922 billion to $1.23 trillion over the next decade. Key advancements include the rise of genomic sequencing, bioinformatics and biomarker identification, which enable the development of targeted therapies and individualised treatment plans.
The whitepaper analyses these trends and offers insights into how personalised medicine is redefining the future of healthcare.